Travere Therapeutics Inc (NASDAQ:TVTX)
| 27.58 Delayed Data As of Aug 12 |  +0.43 / +1.58%Today’s Change | 13.75 Today|||52-Week Range 31.65 | -11.15% Year-to-Date |
Institutional investors purchased a net $4.6 million shares of TVTX during the quarter ended June 2019. This may signal that the smart money is gaining interest in this company as the 107.34% of shares outstanding that institutional investors hold is actually below the Biotechnology industry average.
| Other institutional | 69.61% |
| Mutual fund holders | 37.73% |
| Individual stakeholders | 1.29% |
Largest Quarterly Institutional
Transactions
Latest Institutional Activity
| 6/30/2022 | ASSENAGON ASSET MANAGEMENT SA (G... Bought 639.1 Thousand shares of Travere Therapeutics Inc |
| 6/30/2022 | ARCTIC FUND MANAGEMENT AS (SWEDE... Bought 41.8 Thousand shares of Travere Therapeutics Inc |
| 6/30/2022 | GLOBAL X MANAGEMENT CO. LLC Bought 17.6 Thousand shares of Travere Therapeutics Inc |
Top 10 Owners of Travere Therapeutics Inc
| Stockholder | Stake | Shares owned | Total value ($) | Shares bought / sold | Total change |
|---|---|---|---|---|---|
| Armistice Capital LLC | 7.81% | 4,958,000 | 120,132,340 | +880,000 | +21.58% |
| RA Capital Management LP | 7.75% | 4,922,941 | 119,282,860 | -691,487 | -12.32% |
| Janus Henderson Investors US LLC | 6.52% | 4,141,847 | 100,356,953 | +125,689 | +3.13% |
| BlackRock Fund Advisors | 6.18% | 3,921,683 | 95,022,379 | -25,778 | -0.65% |
| The Vanguard Group, Inc. | 5.92% | 3,762,736 | 91,171,093 | -28,040 | -0.74% |
| Macquarie Investment Management B... | 5.69% | 3,611,269 | 87,501,048 | -154,991 | -4.12% |
| Deep Track Capital LP | 5.41% | 3,435,200 | 83,234,896 | +300,697 | +9.59% |
| Baker Bros. Advisors LP | 5.20% | 3,300,009 | 79,959,218 | +630,955 | +23.64% |
| SSgA Funds Management, Inc. | 4.66% | 2,959,361 | 71,705,317 | +72,284 | +2.50% |
| Goldman Sachs & Co. LLC (Private ... | 3.55% | 2,252,693 | 54,582,751 | -13,440 | -0.59% |
Top 10 Mutual Funds Holding Travere Therapeutics Inc
| Mutual fund | Stake | Shares owned | Total value ($) | Shares bought / sold | Total change |
|---|---|---|---|---|---|
| Delaware Small Cap Core Fund | 4.58% | 2,910,690 | 70,526,019 | -295,163 | -9.21% |
| SPDR S&P Biotech ETF | 3.88% | 2,465,867 | 59,747,957 | -58,344 | -2.31% |
| Vanguard Total Stock Market Index... | 2.95% | 1,872,945 | 45,381,457 | +21,705 | +1.17% |
| iShares Russell 2000 ETF | 2.13% | 1,349,882 | 32,707,641 | -1,362 | -0.10% |
| Janus Henderson Global Life Scien... | 1.58% | 1,003,363 | 24,311,485 | +22,867 | +2.33% |
| Janus Henderson Capital Funds Plc... | 1.44% | 913,748 | 22,140,114 | -11,546 | -1.25% |
| Vanguard Extended Market Index Fu... | 1.09% | 690,659 | 16,734,668 | +9,322 | +1.37% |
| Janus Henderson Venture Fund | 0.98% | 624,927 | 15,141,981 | 0 | 0.00% |
| iShares Biotechnology ETF | 0.76% | 480,149 | 11,634,010 | -2,562 | -0.53% |
| Fidelity Small Cap Index Fund | 0.73% | 463,853 | 11,239,158 | 0 | 0.00% |